Hospital Tengku Ampuan Rahimah

Klang 41200

1 studies enrolling now · 5 studies all time

What they study most

Diabetes Mellitus, Type 2, Ischemic Stroke; Ischemic Attack, Transient, Kidney Disease, Chronic, Lupus Nephritis

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
• An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis — Completed
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed